Prescribing overview
Short-acting beta2 agonist used for bronchospasm; inhaled veterinary evidence includes cats and horses.
An airway smooth-muscle relaxant; not an anti-inflammatory controller.
Key prescribing checks
- Feline experimental research found increased airway inflammation with repeated racemic albuterol; it should not replace an anti-inflammatory plan.
- Equine clinical research supports rapid inhaled bronchodilation.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Cats
Extra-label veterinary evidence; not an animal product approvalBronchodilator use in experimental feline airway disease
Repeated racemic exposure raised inflammatory concerns.
Use / indication source ↗Horses
Extra-label veterinary evidence; not an animal product approvalBronchospasm with recurrent airway obstruction
Clinical study documented rapid bronchodilation.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Beta2-receptor activation promotes bronchodilation.
Absorption, distribution, metabolism and elimination
Inhaled delivery depends on the device and mask fit; equine onset and duration were measured in a clinical trial. No cross-species conversion is provided.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Albuterol Sulfate HFA
Human inhaler label; veterinary extrapolation.
Contraindications · when not to use
- Ingredient hypersensitivity.
Precautions & monitoring
- Paradoxical bronchospasm, cardiovascular effects and low potassium are warnings.
Albuterol Sulfate Syrup
Human oral label; not an animal prescription.
Contraindications · when not to use
- Known albuterol or component hypersensitivity.
Precautions & monitoring
- Systemic cardiovascular effects warrant review.
A human approval does not establish an animal-approved indication.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Tremor, tachycardia and hypokalemia are human-label risks.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No animal dosing is supplied. The veterinarian must select the exact formulation, delivery device and individual regimen.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Albuterol Sulfate HFA
Human inhaler label; veterinary extrapolation.
- Review beta-blockers, loop/thiazide diuretics, MAO inhibitors, TCAs and other adrenergic drugs.
Albuterol Sulfate Syrup
Human oral label; not an animal prescription.
- Other sympathomimetics and antidepressants require review.
Monitoring
Breathing effort and rescue-treatment frequency; heart rate and potassium when indicated.
Client counseling
Follow the veterinarian's rescue plan; worsening breathing requires urgent care.
Have mask/spacer technique demonstrated; oral syrup cannot refill an inhaler.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow presentation-specific priming, cleaning and storage instructions; keep pressurized canisters away from heat.
Brands, formulations & ingredient identity
Active ingredients
Albuterol sulfate
Other searchable names: salbutamol · Ventolin · ProAir · Proventil
HFA inhalers, nebulizer liquids and oral syrup are different presentations; do not substitute routes or devices.
This entry covers albuterol alone; combination inhalers and levalbuterol are different products.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Albuterol Sulfate HFA
- Formulation
- Metered-dose inhalation aerosol
- Label / product scope
- Human product
Human product; veterinary use requires a prescription. Inhaled presentation.
Product label / source ↗Albuterol Sulfate Syrup
- Formulation
- Oral syrup
- Label / product scope
- Human product
Human product; veterinary use requires a prescription. Not inhaler liquid.
Product label / source ↗References & review status
Clinical reference updated October 26, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
